Moffitt Notice of Blackbaud Data Incident. Learn More
Your Neuroendocrine Tumor Specialists
The neuroendocrine tumor specialists at Moffitt Cancer Center have the highly focused expertise necessary to understand and treat neuroendocrine tumors of the gastrointestinal system. Our high level of specialization is important because these relatively rare tumors behave – and must be managed – differently than other types of tumors. Moffitt has extensive experience in diagnosing and treating all types of cancer, including very rare and complex neuroendocrine tumors. As a result, our patient outcomes and quality of life consistently exceed the national averages, and we have helped thousands of patients win their battles against cancer.
The multispecialty tumor board of experts in Moffitt’s Gastrointestinal Oncology Program is made up of a variety of neuroendocrine tumor specialists, each of whom focuses on a specific aspect of cancer treatment or support. Our team includes:
- Gastrointestinal cancer surgeons
- Medical oncologists
- Radiation oncologists
- Endoscopy technicians
With a commitment to treating people, rather than just conditions, the neuroendocrine tumor specialists at Moffitt emphasize patient education and communication. Because we firmly believe that informed individuals make the best treatment decisions, we encourage questions at any time. Our supportive care specialists also offer a variety of services designed to help each patient have the best possible quality of life both during and after treatment.
As a highly regarded leader in cancer research and treatment, Moffitt has established a robust clinical trials program, which provides our patients with unique opportunities to access newly discovered options as soon as they become available. In fact, many of our patients are among the first in the nation to benefit from promising new therapies.
By consistently meeting the rigorous standards set by the National Cancer Institute (NCI), Moffitt has earned the NCI’s Comprehensive Cancer Center designation. This prestigious recognition is a testament to our groundbreaking research and ongoing commitment to bettering the lives of all current and future cancer patients.